Your browser doesn't support javascript.
loading
Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs.
Ishizawa, Jo; Kojima, Kensuke; McQueen, Teresa; Ruvolo, Vivian; Chachad, Dhruv; Nogueras-Gonzalez, Graciela M; Huang, Xuelin; Pierceall, William E; Dettman, E J; Cardone, Michael H; Shacham, Sharon; Konopleva, Marina; Andreeff, Michael.
Affiliation
  • Ishizawa J; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Kojima K; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Hematology, Respiratory Medicine and Oncology, Department of Medicine, Saga University, Saga, Japan.
  • McQueen T; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Ruvolo V; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Chachad D; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Nogueras-Gonzalez GM; Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Huang X; Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Pierceall WE; Eutropics Pharmaceuticals, Cambridge, Massachusetts, United States of America.
  • Dettman EJ; Eutropics Pharmaceuticals, Cambridge, Massachusetts, United States of America.
  • Cardone MH; Eutropics Pharmaceuticals, Cambridge, Massachusetts, United States of America.
  • Shacham S; Karyopharm Therapeutics, Boston, Massachusetts, United States of America.
  • Konopleva M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Andreeff M; Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
PLoS One ; 10(9): e0138377, 2015.
Article in En | MEDLINE | ID: mdl-26375587
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Gene Expression Regulation, Neoplastic / Apoptosis / Gene Expression Profiling / Mitochondria / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Gene Expression Regulation, Neoplastic / Apoptosis / Gene Expression Profiling / Mitochondria / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Year: 2015 Document type: Article